Related Articles
Therapeutic effect and adverse reaction of sorafenib in the treatment of advanced renal cancer
A single-center experience of sorafenib monotherapy in patients with advanced intrahepatic cholangiocarcinoma
Clinical significance of gefitinib antitumor activity in patients with lung adenocarcinoma
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy
Comparison of standard-dose and half‑dose sorafenib therapy on clinical outcome in patients with unresectable hepatocellular carcinoma in field practice: A propensity score matching analysis